$NMTR

9 Meters Biopharma Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Computer Storage Device Manufacturing

PRICE

$0.47 ▲4.934%

Extented Hours

VOLUME

1,146,019

DAY RANGE

0.45 - 0.49

52 WEEK

0.3501 - 1.55

Join Discuss about NMTR with like-minded investors

See 2 more NMTR posts
profile
@JordanBirdie #LWT Trading
recently

ouch mate, you must have been playing with a lot of shares. what was your stop loss like? > @sulleytrim said: NMTR

107 Replies 6 👍 7 🔥

profile
@dros #droscrew
recently

+Initiations 1/29: $AIRC $AMRC $AWH $BLU $HSKA $ICAD $IDXX $IGMS $LSCC $NMTR $PAGS $PEIX $RSI $STNE $VIVE $XL $XPEV . -Initiations 1/29: $RLGY

91 Replies 9 👍 10 🔥

profile
@PradeepB #droscrew
recently

NMTR DGLY breaking out

49 Replies 6 👍 6 🔥

Load more...

Key Metrics

Market Cap

124.50 M

Beta

1.10

Avg. Volume

1.36 M

Shares Outstanding

259.11 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

9 Meters Biopharma, Inc. ('the Company') is a rare and unmet needs-focused gastroenterology company. The Company is advancing NM-002, a proprietary long-acting GLP-1 agonist into a Phase 2 trial for short bowel syndrome (SBS), a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom improvement in non-responsive celiac disease.

CEO: Sandeep Laumas

Website:

HQ: 8480 Honeycutt Rd Ste 120 Raleigh, 27615 North Carolina

Related News